Phase 2 Breast Cancer Trial, Not Yet Recruiting
voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice
Who may and may not be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who may be able to join
- Women with breast cancer aged 18 or older, whether they have gone through menopause or not.
- People with a confirmed breast cancer type that is hormone receptor-positive (meaning the cancer is fuelled by hormones) and HER2-negative (a specific protein is not overactive), based on laboratory testing of tissue samples.
- People confirmed to have invasive breast cancer that, after surgery, was found to be at stage II or III.
- People who have or have not received chemotherapy before or after surgery are considered.
- Surgery must have taken place no more than 12 months before joining the trial.
- People who received radiotherapy must have recovered from the immediate side effects, with at least 14 days passed since the end of radiotherapy before joining.
- People who received chemotherapy must have recovered from most immediate side effects (rated at a mild level or below), with at least 21 days passed since the last chemotherapy treatment before joining — hair loss and mild nerve-related side effects are exceptions to this recovery requirement.
- People with a general health and activity level rated as 0 or 1 on a standard medical scale, meaning fully active or able to carry out light activity (confirm with trial site).
- People whose blood test results meet specific levels for white blood cells, platelets, haemoglobin, liver function markers, kidney function markers, and other blood measures as required by the trial.
- People whose heart electrical activity, measured by a standard heart tracing (ECG), shows a specific interval reading below a set threshold.
- People who are willing to take part voluntarily, sign a consent form, follow the trial requirements, and attend follow-up appointments.
Who may not be able to join
Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.
- People with stage IV breast cancer, or breast cancer that has come back or spread to other parts of the body, or a type called inflammatory breast cancer.
- People with a history of any other cancer, or who have previously received cancer treatment or radiotherapy for another cancer — with exceptions for certain fully treated cancers such as early cervical, basal cell skin cancer, or squamous cell skin cancer.
- People who are currently taking part in another clinical trial.
- People who have received a blood transfusion or certain blood-boosting treatments in the two weeks before joining.
- People with a known allergy to any of the drugs used in this trial.
- People with a history of immune system problems, including a positive HIV test, other immune deficiency conditions, or a history of organ transplant.
- People with a history of heart conditions, including chest pain (angina), irregular heartbeat requiring treatment, heart attack, heart failure, or any other heart condition considered unsuitable by the treating doctor.
- People who are pregnant or breastfeeding.
- People with any other condition that the treating doctor considers makes participation unsuitable.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +86 13960709993
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Primary endpoints
3-years Invasive Disease-Free Survival (iDFS)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 10 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.